A non-interventional, post-authorisation safety study of patients treated with efgartigimod alfaFirst published 13/03/2024 Last updated 13/03/2024 EU PAS number: EUPAS1000000019StudyOngoing
United BioSource Corporation (UBC)Switzerland First published: 25/04/2013Last updated 06/03/2024 InstitutionNon-Pharmaceutical companyENCePP partner